Alexandra Diot

1.4k total citations · 1 hit paper
14 papers, 1.0k citations indexed

About

Alexandra Diot is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Alexandra Diot has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Alexandra Diot's work include Cancer-related Molecular Pathways (12 papers), RNA modifications and cancer (6 papers) and Ubiquitin and proteasome pathways (3 papers). Alexandra Diot is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), RNA modifications and cancer (6 papers) and Ubiquitin and proteasome pathways (3 papers). Alexandra Diot collaborates with scholars based in United Kingdom, United States and France. Alexandra Diot's co-authors include Jean‐Christophe Bourdon, Kenneth Fernandes, David P. Lane, Geng Liu, Mark K. Saville, Dimitris P. Xirodimas, Virginie Marcel, Mustapha Aoubala, Marie P. Khoury and Michael J. Groves and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Cancer Research.

In The Last Decade

Alexandra Diot

14 papers receiving 1.0k citations

Hit Papers

p53 isoforms can regulate p53 transcriptional activity 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Diot United Kingdom 10 762 724 228 183 65 14 1.0k
Marie P. Khoury United Kingdom 8 535 0.7× 433 0.6× 175 0.8× 89 0.5× 34 0.5× 10 774
Linghu Nie United States 15 668 0.9× 470 0.6× 134 0.6× 100 0.5× 108 1.7× 18 843
Sebastian Kehrloesser Germany 13 574 0.8× 374 0.5× 194 0.9× 86 0.5× 48 0.7× 15 771
Andrea Prodosmo Italy 17 730 1.0× 538 0.7× 148 0.6× 63 0.3× 125 1.9× 18 923
Jacqueline E. Noll Australia 15 549 0.7× 421 0.6× 239 1.0× 70 0.4× 81 1.2× 23 923
Nikia A. Laurie United States 10 455 0.6× 485 0.7× 131 0.6× 68 0.4× 38 0.6× 12 756
Alicia White United States 4 867 1.1× 881 1.2× 300 1.3× 224 1.2× 131 2.0× 6 1.3k
Loretta Raycroft United States 9 625 0.8× 632 0.9× 155 0.7× 214 1.2× 52 0.8× 10 998
Avi Shvarts Netherlands 11 717 0.9× 532 0.7× 491 2.2× 151 0.8× 51 0.8× 18 1.1k
Louise Aagaard Austria 6 921 1.2× 664 0.9× 133 0.6× 95 0.5× 174 2.7× 7 1.2k

Countries citing papers authored by Alexandra Diot

Since Specialization
Citations

This map shows the geographic impact of Alexandra Diot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Diot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Diot more than expected).

Fields of papers citing papers by Alexandra Diot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Diot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Diot. The network helps show where Alexandra Diot may publish in the future.

Co-authorship network of co-authors of Alexandra Diot

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Diot. A scholar is included among the top collaborators of Alexandra Diot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Diot. Alexandra Diot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Robertson, Claire, et al.. (2022). Δ133p53 coordinates ECM-driven morphogenesis and gene expression in three-dimensional mammary epithelial acini. Journal of Cell Science. 135(21). 5 indexed citations
2.
Li, Muyang, et al.. (2022). A Novel Role of SMG1 in Cholesterol Homeostasis That Depends Partially on p53 Alternative Splicing. Cancers. 14(13). 3255–3255. 2 indexed citations
3.
Schubert, Stephanie, Noel F.C.C. de Miranda, Dina Ruano, et al.. (2018). PO-059 Cancer-predisposing variants in alternatively spliced TP53 exons. ESMO Open. 3. A249–A250. 1 indexed citations
4.
Lardy-Cléaud, Audrey, Susan E. Bray, Sylvie Chabaud, et al.. (2018). Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes. Cancers. 10(10). 390–390. 12 indexed citations
5.
Gadéa, Gilles, Nikola Arsic, Kenneth Fernandes, et al.. (2016). TP53 drives invasion through expression of its Δ133p53β variant. eLife. 5. 50 indexed citations
6.
Mao, Xianqing, Michael W.H. Coughtrie, Sandrine Gulberti, et al.. (2016). The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer. Oncogene. 35(38). 5043–5055. 23 indexed citations
7.
Khoury, Marie P., Virginie Marcel, Kenneth Fernandes, et al.. (2012). Detecting and Quantifying p53 Isoforms at mRNA Level in Cell Lines and Tissues. Methods in molecular biology. 962. 1–14. 12 indexed citations
8.
Marcel, Virginie, Marie P. Khoury, Kenneth Fernandes, et al.. (2012). Detecting p53 Isoforms at Protein Level. Methods in molecular biology. 962. 15–29. 18 indexed citations
9.
Marcel, Virginie, Isabelle Petit, Théo Goullet de Rugy, et al.. (2011). Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity. Cell Death and Differentiation. 19(5). 816–826. 48 indexed citations
10.
Bourdon, Jean‐Christophe, Marie P. Khoury, Alexandra Diot, et al.. (2011). p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients. Breast Cancer Research. 13(1). R7–R7. 85 indexed citations
11.
Marcel, Virginie, Stéphane Perrier, Mustapha Aoubala, et al.. (2010). Δ160p53 is a novel N‐terminal p53 isoform encoded by Δ133p53 transcript. FEBS Letters. 584(21). 4463–4468. 105 indexed citations
12.
Thompson, Alastair M., Nancy Patten, Alexandra Diot, et al.. (2007). The clinical relevance of p53 isoforms modifying the effects of p53 mutation on survival from breast cancer. Journal of Clinical Oncology. 25(18_suppl). 10505–10505. 1 indexed citations
13.
Dudgeon, Crissy, Calvina Kek, Oleg N. Demidov, et al.. (2006). Tumor Susceptibility and Apoptosis Defect in a Mouse Strain Expressing a Human p53 Transgene. Cancer Research. 66(6). 2928–2936. 18 indexed citations
14.
Bourdon, Jean‐Christophe, Kenneth Fernandes, Geng Liu, et al.. (2005). p53 isoforms can regulate p53 transcriptional activity. Genes & Development. 19(18). 2122–2137. 631 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026